Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex

AIDS. 1998 Jul 9;12(10):F91-5. doi: 10.1097/00002030-199810000-00001.

Abstract

Background: Advances in the treatment of HIV disease with protease inhibitor combination therapies have been widely documented in the media.

Objectives: To investigate perceptions concerning the severity of HIV/AIDS and the need to maintain safer sex practices in the light of recent HIV treatment advances.

Methods: A survey eliciting demographic characteristics, HIV serostatus and treatment information, and HIV/AIDS severity and safer sex perceptions was administered to a community sample of 379 homo-/bisexual men who reported awareness of combination therapy regimens.

Results: Ten per cent of all respondents agreed or strongly agreed with the statement that 'AIDS is now very nearly cured' and 13% felt that the threat of AIDS is less serious than in the past. HIV-positive men were more likely to perceive AIDS as a less serious threat or as very nearly cured. Overall, 8% of men in the sample indicated that they practice safer sex less often since new AIDS treatments came along; 18% of HIV-positive men on combination therapy regimens said they practice safer sex less frequently since treatments have advanced. Regardless of serostatus, nearly 20% of men indicated they would stop practicing safer sex if an AIDS cure was announced.

Conclusion: It is essential to integrate behavior change counseling into HIV treatment programs and to temper optimism concerning treatment advances with recognition that the threat of HIV/AIDS remains great.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / psychology
  • Attitude to Health
  • Bisexuality / psychology
  • Drug Therapy, Combination
  • HIV / immunology*
  • HIV Protease Inhibitors / therapeutic use*
  • Homosexuality, Male / psychology*
  • Humans
  • Male
  • Midwestern United States
  • Risk Assessment
  • Sexual Behavior* / psychology

Substances

  • HIV Protease Inhibitors